Related Experiment Video
Updated: Jun 19, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Barriers to addressing overweight and obesity before conception.
Leonie K Callaway1, Michael J O'Callaghan, H David McIntyre
1Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. l.callaway@uq.edu.au
The Medical Journal of Australia
|October 20, 2009
Summary
Many women face challenges managing weight before pregnancy, including poor health check attendance and inaccurate self-perception of weight. Addressing these issues is crucial for preconception health.
Area of Science:
- Reproductive Health
- Public Health
- Obstetrics
Background:
- Overweight and obesity before conception pose risks to maternal and infant health.
- Addressing prepregnancy weight is a key public health concern.
Purpose of the Study:
- To identify challenges women encounter when attempting to manage overweight and obesity prior to conception.
- To explore barriers to effective preconception weight management.
Main Methods:
- A questionnaire-based study surveyed 412 women in early pregnancy.
- Participants were recruited from both public antenatal clinics and private obstetric practices in Brisbane.
- Data collected included preconception health activities, prepregnancy body mass index (BMI), self-reported weight categories, and weight loss behaviors and advice.
Main Results:
- 30% of women were overweight or obese before pregnancy.
- A significant number of overweight (36%) and obese (16%) women miscategorized their weight.
- Increased body mass index correlated with higher rates of attempting weight loss and receiving weight loss advice (P < 0.001).
- 45% of overweight and obese women reported attempting prepregnancy weight loss.
Conclusions:
- Barriers to addressing prepregnancy overweight and obesity include low engagement with preconception health services.
- Inaccurate self-assessment of weight status is a significant issue.
- Unsuccessful weight loss attempts and insufficient guidance on prepregnancy weight management present further challenges.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:26Stress Prevention and Stress Management Techniques IV
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Strategies for Assessing and Addressing Confounding
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...